Catch-up on the Progressive MS Alliance webcasts
Advances in treatment and research.
Last updated: 24th June 2024
What’s on this page?
Catch-up on previous Alliance webcasts below
Click the settings toggle in the bottom right corner to watch the video with English, Spanish, Italian, Arabic or French subtitles.
Mobility challenges in progressive MS
People with MS often experience mobility challenges and limitations, including difficulty walking, abnormal gait, loss of balance, fatigue and weakness. Fortunately, there are treatments and assistive devices available to help improve mobility.
Hear from a panel of three researchers who are dedicated to finding ways to diagnose people’s individual challenges more quickly and accurately to intervene with solutions to help improve mobility – and ultimately, quality of life for people living with MS.
New treatments for progressive MS
New, effective treatments are urgently needed for people with progressive MS. Hear from leading MS experts about the current state of treatments for progressive MS, active clinical trials that may provide new solutions, and research efforts to develop breakthrough treatments to ultimately end MS progression.
Cognitive impairment and MS
Cognitive impairment is common in MS, and people with MS frequently report difficulties, such as following along in complex conversations, recalling information and forgetfulness. These cognitive challenges can impact the successful completion of everyday tasks. Fortunately, there are proven strategies that can help manage these challenges and research is providing insights into new solutions for people with progressive MS. Learn about the latest advances in treatment and research in cognition and MS during this global webcast. From simple ways to manage or reduce cognitive challenges to research seeking the cause and developing new treatments, this webcast provides information to help improve your quality of life and keep you informed.
Ending MS progression
Recorded live from the International Progressive MS Alliance Scientific Congress in Vienna, Austria, watch the recording to hear results from 17 innovative research projects funded by the Alliance. Each project is focused on unraveling the mystery of progression and identifying new targets for treatments that will ultimately slow or stop progression. A panel of international MS experts shared findings and insights that not only inspire hope but demonstrate real progress in ending progressive MS. Click the link below to watch the 30-minute global webcast.
Developing treatments to end MS progression: Recent advances and promising research
New, life-changing treatments are urgently needed for people with progressive MS. Hear from leading MS experts about the current state of treatments for progressive MS, active clinical trials that may provide new solutions, and research efforts to develop breakthrough treatments to ultimately end MS progression.
Expert panelists include Dr. Jeffrey Cohen, Professor of Neurology in the Cleveland Clinic Lerner College of Medicine in the US and a leader in a large number of MS clinical trials; Dr. Jiwon Oh, staff neurologist, scientist, and Medical Director of the Barlo Multiple Sclerosis (MS) Program at St. Michael’s Hospital in Canada; Dr. Emma Gray, Assistant Director of Research at the MS Society, UK, and leader of the strategic development of the MS Society’s broad research programme including the ground-breaking OCTOPUS clinical trial platform. The webcast was hosted by Marie Vaillant, an international leader in the MS movement from Canada, a member of the International Progressive MS Alliance Scientific Steering Committee, and a person living with progressive MS.
Pain in progressive MS: advancing treatment and research
Pain can be one of the most difficult ‘invisible’ symptoms to describe and manage. Up to two-thirds of people with MS report pain in worldwide studies. Those who experience pain may find it affects their daily life activities, such as work, recreation, mood and enjoyment of life.
Learn about the latest advances in treatment and research on the topic of pain during this 30-minute global webcast. An international panel of MS experts answered questions submitted by people affected by MS throughout the world. From ways to manage or reduce pain, to research seeking its cause, and developing new treatments, this webcast provides information to help improve quality of life and keep you informed.
Solving the mystery of progression: the key to new treatments for progressive MS
Understanding what leads to progression is key to developing breakthrough treatments for people with progressive MS. Learn about 18 innovative research projects funded by the International Progressive MS Alliance focused on unraveling the mystery of progression and identifying new targets for treatments, that will ultimately slow or stop progression. A panel of international MS experts will share findings and insights that not only inspire hope but demonstrate real progress in ending progressive MS.
Ending progressive MS
Professors Robert Fox and Ruth Ann Marrie, International Progressive MS Alliance researchers and neurologists, will share what we are learning about progressive MS and the launch of important, new research initiatives that will fuel the development of breakthrough treatments for progressive MS. Don’t miss this 30-minute webcast.
There is an urgent need for new, effective treatments for people with progressive MS. Learn how the Progressive MS Alliance is driving three research priorities to meet that urgent need:
- Understand, prevent and reverse progression
- Speed up and improve clinical trials
- Improve well-being through proven therapeutic approaches
Answering questions on fatigue in progressive MS
Find out more about the panellists here.
Answering questions on progressive MS treatment and research
Find out more about the panellists here.
Accelerating Breakthough Treatments in Progressive MS
Find out more about the panellists here.
How a blood test and the use of artificial intelligence in MRIs could be game-changers
Find out more about the panellists here.